Increased Dietary Vitamin C Intake May Help Reduce Gout Risk, Study Finds
HCPLive
OCTOBER 12, 2024
The analysis of NHANES data revealed an inverse association between dietary vitamin C intake and gout risk.
HCPLive
OCTOBER 12, 2024
The analysis of NHANES data revealed an inverse association between dietary vitamin C intake and gout risk.
Dr. Smith's ECG Blog
OCTOBER 12, 2024
Written by Bobby Nicholson What do you think of this “STEMI”? A man in his 90s with a history of HTN, CKD, COPD, and OSA presented to the emergency department after being found unresponsive at home. With EMS, patient had a GCS of 3 and was saturating 60% on room air. He improved to 100% with the addition of non-rebreather, however remained altered and was intubated by EMS with ketamine and succinylcholine.
HCPLive
OCTOBER 12, 2024
This analysis indicates that patients with a history of a first melanoma are at risk for subsequent development of melanoma regardless of their race or their ethnicity.
Med Page Today
OCTOBER 12, 2024
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.
HCPLive
OCTOBER 12, 2024
Results from INVIGORATE-2 showed IV secukinumab led to improved clinical measures of PsA, with a similar safety profile to subcutaneous secukinumab.
HCPLive
OCTOBER 12, 2024
Research from Spain suggests long-term opioid use to treat fibromyalgia pain significantly raises the risk of depression, anxiety and sleep disorders in patients.
HCPLive
OCTOBER 12, 2024
Secukinumab is best for severe skin involvement, while adalimumab improves synovitis in PsA. Both are effective, but larger studies are needed for long-term outcomes.
Let's personalize your content